PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...
Avalon BioVentures managing partners Sergio Duron and Sandy Madigan hadn’t even left their previous start-up when they hatched the idea for Enlaza Therapeutics. While they were both still at Nerio ...
Expedition Medicines, which Flagship Pioneering Inc. has incubated for the past three years, came out of stealth mode with a $50 million commitment from Flagship to support Expedition’s platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback